Pharmacotherapy of late-life generalized anxiety disorder.
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder
- Focus Pharmacogenomic; Therapeutic Use
- 21 Jan 2009 Results reported in JAMA: the Journal of the American Medical Association
- 08 Sep 2008 Primary outcome updated as reported by ClinicalTrials.gov.
- 08 Sep 2008 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History